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The purpose of this study was to genotype strains of Candida albicans to determine whether specific types
were associated with chronic hyperplastic candidosis (CHC). A total of 67 candidal isolates from CHC patients
(n  17) and from patients with other oral conditions (n  21) were genotyped by PCR fingerprinting
employing two interrepeat primer combinations (1245 and 1246 primers or 1251 primer) and a single mini-
satellite-specific M13 primer. The most suitable primer for fingerprint analysis was found to be primer 1251,
yielding well-resolved banding patterns. For the 67 isolates tested, PCR fingerprinting delineated 25 (1245 and
1246 primers), 27 (1251 primer), and 25 (M13 primer) profiles. The majority of C. albicans isolates from
multiple sites within the mouth produced identical profiles (six out of nine subjects examined). For patients
for whom a series of longitudinal isolates was available, strain persistence for up to 7 years was evident for five
out of eight individuals, despite episodes of antifungal therapy. Computer-assisted comparison of the inter-
repeat PCR fingerprints identified seven distinct profiles that were shared among isolates from different
individuals. However, no association was evident among isolates of C. albicans from specific clinical conditions.
Eight isolates that were initially identified as C. albicans but having atypical PCR profiles were later confirmed
as Candida dubliniensis. In conclusion, the genotypic data do not indicate clonal restriction of C. albicans with
respect to CHC. Furthermore, these results have demonstrated that in the majority of individuals, colonizing
populations of C. albicans are clonal in nature and exhibit strain persistence.
The opportunistic pathogen Candida albicans is responsible
for a range of human infections (candidoses). While systemic
infection by the organism can occur, particularly in the immu-
nocompromised individual, superficial forms of infection af-
fecting the oral and vaginal mucosa are most prevalent (21).
Oral candidosis most frequently presents as removable pseu-
domembranes or areas of erythema, particularly under den-
tures. Chronic hyperplastic candidosis (CHC) is a rarer oral
infection associated with the invasion of candidal hyphae into
the surface epithelium (2). Clinically, CHC appears as a speck-
led or homogeneous white patch that cannot be removed by
gentle scraping of the mucosa, thereby distinguishing it from
pseudomembranous and erythematous forms of candidosis. A
biopsy of the white patch is required for a definitive diagnosis
of CHC and histopathological examination typically reveals a
hyperplastic keratinized epithelium that is heavily infiltrated
with neutrophils and invaded by candidal hyphae.
The importance of CHC is its reported association with the
development of malignancy at the lesional site (2). The role of
candida in this dysplastic change remains unclear. It has been
suggested that the presence of candida represents a secondary
infection within a preexisting altered epithelium. However,
clinical resolution of CHC and a reduction in the extent of
epithelial dysplasia following systemic antifungal therapy have
supported a direct role for candida (11). In addition, a corre-
lation between histologically confirmed fungal invasion and
epithelial dysplasia in oral mucosal lesions has been reported
(1). Furthermore, the ability of certain C. albicans strains to
promote neoplastic changes (22) and to produce carcinogenic
nitrosamines from saliva (9) has highlighted the potential role
of candida in malignant transformation.
There is evidence to suggest that particular strains of C.
albicans are associated with specific forms of oral candidosis.
Examples include biotype differences between isolates from
CHC and normal mucosa and phenotypic variation between
isolates recovered from speckled and homogeneous forms of
CHC (10, 25). However, a recent biotyping investigation per-
formed at Cardiff Dental School failed to identify such clonal
restriction of 35 C. albicans isolates from CHC (43). The main
problem of biotyping C. albicans is that a large number of
epidemiologically unrelated strains frequently have identical
biotypes, with a single profile predominating for the majority
of isolates (36).
Genotyping methods based on nucleic acid analysis poten-
tially offer greater discrimination and reproducibility for strain
delineation than phenotyping (18). PCR-based strategies have
evolved as some of the most useful methods for candidal geno-
typing. Repetitive DNA sequences exist that display extensive
allelic variation, including enterobacterial repetitive intergenic
consensus (ERIC) sequences (39) and telomeric DNA (26) in
prokaryotes and eukaryotes, respectively. Consensus primers
to these elements have been designed to enable PCR amplifi-
cation of polymorphic loci between neighboring repetitive el-
ements. This procedure, termed interrepeat PCR (IR PCR),
generates unambiguous DNA fingerprints that enable differ-
entiation of C. albicans strains (37). A similar PCR technique
exists in which a single primer specific to the core sequence of
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phage M13 minisatellite DNA is employed to amplify hyper-
variable genomic DNA sequences (38).
The major advantage of PCR-based typing is that it requires
little starting material, has universal application, and is rapid
and simple to perform. The discriminatory power of two IR
PCR assays has also been found to be comparable to that of
the more established complex techniques of total genomic
DNA digestion, electrophoretic karyotyping, and Southern hy-
bridization with C. albicans-specific probes (3, 37).
Despite the high frequency of commensal carriage of C.
albicans and its prominence as a major fungal pathogen, little
is known concerning its genetic homogeneity, evolution, and
persistence during commensalism and infection. The develop-
ment of genotypic techniques has allowed the assessment of
strain relatedness at the genetic level and facilitated epidemi-
ological analysis (35). DNA fingerprinting has been applied to
investigate strain persistence during chronic or recurrent in-
fection or relapse following antifungal therapy, microevolution
in infecting populations, and the origin of candidosis. Attempts
have also been made to identify strain types associated with
particular disease conditions, anatomical sites, or geographic
locales. These issues underscore the need for fingerprinting
methods which provide measures of genetic distance between
strains and which are amenable to computer-assisted methods
for generating large databases for comparative and retrospec-
tive analyses (29).
The present study describes the use of PCR fingerprinting to
determine the genetic relatedness among isolates of C. albicans
in a retrospective analysis of the epidemiology of CHC and
other forms of oral candidosis. Three molecular typing assays
involving IR PCR (n  2) and M13 PCR fingerprinting were
evaluated and the genotypes of C. albicans isolates from CHC
and non-CHC infections were compared in an effort to deter-
mine whether clonal restriction occurs in CHC. In addition, the
analysis of sequential isolates was applied longitudinally to
monitor C. albicans infection and colonization in a group of
individuals and the type of isolates at multiple sites within an
individual.
MATERIALS AND METHODS
Isolates and patients. Table 1 provides details of the 67 C. albicans isolates
from the 36 patients used in the study (CHC only, 15 patients; CHC and
non-CHC, 2 patients; non-CHC only, 19 patients). CHC lesions were confirmed
by biopsy for 15 patients. Recovery of candida from the oral cavity involved the
use of an imprint culture on Sabouraud dextrose agar and a differential agar
(Pagano-Levin or Chromagar Candida) when defined clinical lesions were evi-
dent or an oral rinse in other situations. Isolates were identified based on
germ-tube formation and carbohydrate assimilation using the API-20C system
(bioMe´rieux, Basingstoke, United Kingdom) as previously described (41).
Histological investigation. When available, formalin-fixed incision biopsy sec-
tions were stained with hematoxylin-eosin and evaluated for the presence of
epithelial dysplasia. Sections were also stained by the periodic acid-Schiff tech-
nique and evaluated for the presence of candida.
DNA isolation. All biochemicals were purchased from Sigma (Poole, United
Kingdom) unless otherwise stated. A modification of a method used to extract C.
albicans DNA (27) was followed, with the omission of diethyl pyrocarbonate in
the spheroplast lysis buffer. Isolates were cultured overnight at 37°C in yeast
nitrogen base (Difco, East Molesey, United Kingdom) supplemented with 0.5%
(wt/vol) glucose. A 1.5-ml portion of this culture was centrifuged (15,000 rpm for
10 min; Microspin 12; Dupont UK Ltd., Stevenage, United Kingdom) and the
cell pellet was resuspended in 1 ml of 1 M sorbitol. Following centrifugation and
removal of the supernatant, a 1-ml volume of 1 M sorbitol in 50 mM potassium
phosphate buffer (pH 7.5) with 0.1% (vol/vol) 2-mercaptoethanol and 0.2 mg of
lyticase per ml was added. The cell lysis solution was then incubated at 30°C for
30 min and the resulting spheroplasts were harvested by centrifugation. The
spheroplasts were resuspended in 0.5 ml of 50 mM sodium EDTA buffer (pH
8.5) containing 2 mg of sodium dodecyl sulfate per ml and the preparation was
incubated at 70°C for 30 min. A 50-l portion of 5 M potassium acetate was
added to the aqueous layer and the mixture was incubated on ice for 30 min. The
supernatant was decanted into 1 ml of absolute ethanol and clarified by centrif-
ugation. The resulting DNA precipitate was washed twice with 200 l of 70%
ethanol and dried. A 100-l portion of TE buffer (10 mM Tris-HCl, 1 mM
EDTA, pH 7.5) containing 10 g of RNase A per ml was then added to the
precipitate. Following a 15-min incubation at 37°C, 200 l of isopropyl alcohol
was added, the mixture was centrifuged, and the resulting DNA precipitate was
dried. The DNA was resuspended in TE buffer. DNA was quantified by diluting
in sterile water and by measuring the absorbance at 260 nm.
IR PCR genotyping. IR PCR fingerprinting analysis was performed using two
sets of interrepeat primers consisting of a prokaryotic primer pair, 1245 and 1246
(37), and a single eukaryotic repeat primer, 1251 (37). Reaction mixtures (50 l)
consisted of 10 mM Tris-HCl (pH 9.0), 50 mM potassium chloride, 0.1% Triton
X-100, 2.5 mM magnesium chloride, 0.2 mM (each) dNTPs (Roche Diagnostics
Ltd., Lewes, United Kingdom), 1.25 U of Taq polymerase (Promega, Southamp-
ton, United Kingdom), and 0.5 M (each) primers 1245 (5-AAG TAA GTG
ACT GGG GTG AGC G-3) and 1246 (5-ATG TAA GCT CCT GGG GAT
TCA C-3) or primer 1251 (5-TGG GTG TGT GGG TGT GTG GGT GTG-3)
(Life Technologies Ltd., Paisley, United Kingdom). A 5-l volume of the can-
didal genomic DNA preparation (approximately 250 ng) in TE buffer was used
as the template.
All PCR amplifications were carried out in a PCR Express thermal cycler
(Hybaid Ltd., Ashford, United Kingdom). For the prokaryotic repeat primers
1245 and 1246, a program of 35 cycles for 1 min at 94°C, 1 min at 25°C, and 2 min
at 74°C, preceded by a 5-min denaturation at 94°C and followed by a final
extension cycle at 74°C for 10 min, was used. The eukaryotic repeat primer 1251
required a program consisting of 40 cycles for 1 min at 94°C, 2 min at 52°C, and
3 min at 74°C. Repeating the experiments (DNA extraction and PCR) assessed
reproducibility.
M13 PCR fingerprinting. An oligonucleotide derived from the core sequence
of the wild-type phage M13 was used as a single primer for M13 PCR finger-
printing (30). Amplification reactions (50 l) consisted of 5 l of candidal DNA
extract, 10 mM Tris-HCl (pH 9.0), 50 mM potassium chloride, 0.1% Triton
X-100, 1.5 mM magnesium chloride, 0.2 mM (each) dNTPs (Roche Diagnostics
Ltd.), 3 mM magnesium acetate, 2.5 U of Taq polymerase (Promega), and 30 ng
of M13 primer (5-GAG GGT GGC GGT TCT-3; Life Technologies Ltd.).
Thirty-five cycles of 20 s at 94°C, 1 min at 50°C, and 20 s at 72°C were performed,
followed by a single extension cycle at 72°C for 6 min. Reproducibility was
assessed as described previously for IR PCR.
Agarose gel electrophoresis. A 20-l portion of each PCR product was added
to 4 l of gel loading buffer (0.25% bromophenol blue, 0.25% xylene cyanol FF,
and 15% Ficoll type 400; Pharmacia Biotech, St. Albans, United Kingdom) and
2 l of an ethidium bromide solution (500 g/ml). Sample mixtures were loaded
into a 0.75% agarose (Bioline, London, United Kingdom) and 0.75% NuSieve
(Flowgen, Ashby de la Zouch, United Kingdom) gel. In order to estimate the size
of the PCR products and to perform gel normalization, molecular weight mark-
ers consisting of a 100-bp DNA ladder (Life Technologies Ltd.) for primers 1251
and M13 and a 50-bp DNA ladder (Promega) for primers 1245 and 1246 were
electrophoresed concurrently with the PCR products at eight-lane intervals ac-
cording to the manufacturers’ instructions. The agarose gel was placed in an
electrophoresis apparatus (Flowgen) containing 0.5 Tris-borate buffer (45 mM
Tris-borate, 1 mM EDTA, pH 8.3) and a potential of 150 V was applied using an
LKB 2197 DC transformer (Pharmacia LKB, Uppsala, Sweden) for 5 h at 4°C.
PCR profile analysis. The DNA bands were visualized under UV illumination
and the gel image was captured using a GelDoc 1000 system with Molecular
Analyst software version 1.0 (Bio-Rad Laboratories Ltd., Hemel Hempstead,
United Kingdom). The banding profiles for each isolate were compared visually.
In addition, IR PCR fingerprints were analyzed by Gelcompar software, version
1.3 (Applied Maths, Kortrijk, Belgium). The gels were normalized in order to
avoid inter- and intragel variation and aligned by associating bands of the inter-
nal molecular weight standards on each gel with the stored reference positions.
The similarities of the banding profiles of two given isolates were scored using
the Dice coefficient of similarity (4). Matrices of similarity coefficients between
all possible pairs of strains were calculated and cluster analysis was performed by
the unweighted pair group method with arithmetic averages (32). Dendrograms
were constructed to reflect the similarities among the strains in the matrix. The
optimization feature was enabled which allowed small global shifts of up to 5.0%
in patterns that were not perfectly aligned. A tolerance in the band position of
1.5% was applied during the comparison of PCR fingerprinting patterns.
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TABLE 1. Clinical and genotypic data for 67 C. albicans isolates used in the present study
Isolate Date isolated(day.mo.yr)
Patient
no. Infection, location
Severity of
dysplasiac
Hyphal
invasiond
Genotype
(I/II/III)e
576/93 5.10.93 1a CHC, left buccal mucosa Mild None A/a/1
705/93 13.12.93 1 CHC, left buccal mucosa B/b/2
211/00 13.4.00 2 CHC, right commissure ND ND C/c/3
1190/97 5.11.97 3 CHC, right buccal mucosa Moderate  D/d/1
848/99 12.10.99 4 CHC, tongue None  E/e/4
121/94 9.3.94 5 CHC, tongue Moderate  F/f/5
324LA/94 9.6.94 6a,b CHC, left commissure Moderate  G/g/6
324RA/94 9.6.94 6 CHC, right commissure G/g/6
324P/94 9.6.94 6 CHC, palate G/g/6
332T1/97f 4.4.97 6 CHC, tongue Severe  H/h/7
332L1/97 4.4.97 6 CHC, left commissure H/h/7
332R1/97 4.4.97 6 CHC, right commissure H/h/7
965L/97 12.9.97 6 CHC, left buccal mucosa H/h/7
965R/97 12.9.97 6 CHC, right buccal mucosa G/g/6
490/99 25.6.99 6 CHC, commissures H/h/7
455rgh/94 28.7.94 7b CHC, tongue None  I/i/8
455sm/94 28.7.94 7 CHC, tongue I/i/8
456P/94 28.7.94 7 CHC, palate I/i/8
458R/94 29.7.94 8 CHC, right buccal mucosa Mild  J/j/9
674/93 23.11.93 9 CHC, tongue Moderate  K/k/10
688/93 1.12.93 10 CHC, right buccal mucosa Mild  L/l/11
376R/98 5.6.98 11b CHC, right buccal mucosa Mild  M/m/12
376L/98 5.6.98 11 CHC, left buccal mucosa M/m/12
870/99 22.10.99 12 CHC, tongue ND ND N/n/13
600R/93 15.10.93 13a CHC, tongue None  L/l/5
319a/94 1.6.94 13 CHC, tongue L/l/5
775(1)/99 21.9.99 13 CHC, tongue L/l/5
153(1)/00 20.3.00 13 CHC, tongue L/l/5
680/98 16.10.98 14a CHC, palate Mild  A/a/1
80/99 5.2.99 14 CHC, palate A/a/1
552/99 9.7.99 14 CHC, palate A/a/1
PTR/94 1994 15b CHC, right buccal mucosa Moderate  L/l/5
134a/94 15.3.94 16a,b CHC, left buccal mucosa Mild  O/o/14
135BM1/94 15.3.94 16 CHC, left buccal mucosa O/o/14
135BM2/94 15.3.94 16 CHC, left buccal mucosa O/o/14
135MX1/94 15.3.94 16 CHC, maxilla O/o/13
135MX2/94 15.3.94 16 CHC, maxilla O/o/14
655R/93 12.11.93 17 CHC, right buccal mucosa None  N/n/15
640/99 7.8.99 18 Keratosis, tongue Moderate  L/l/11
196D/94 12.4.94 19b Keratosis, denture Mild None L/p/11
196P/94 12.4.94 19 Keratosis, palate P/q/16
819/99 1.10.99 20 Keratosis, sublingual None None L/l/5
79(1)/99 5.2.99 21 Keratosis, sublingual None None L/r/10
372RB/94 24.6.94 22b Keratosis, right buccal mucosa None None Q/s/17
372F/94 24.6.94 22 Keratosis, palate F/f/18
372LB/94 24.6.94 22 Keratosis, left buccal mucosa F/f/18
59a/94 8.2.94 23 Keratosis, right buccal mucosa None None R/t/5
460(1)/98 21.7.98 24 Keratosis, right buccal mucosa None None H/h/7
PTL/94 1994 15 Keratosis, left buccal mucosa None None L/l/11
408/99 26.5.99 25 SCC, tongue NA None S/u/19
32/00 21.1.00 26 SCC, flap NA None D/d/1
34/00 24.1.00 16 Previous SCC, soft palate NA None O/o/14
689/99 24.8.99 27 White patch, tongue ND ND T/v/20
243/00 28.4.00 28 Lichen planus, right buccal mucosa Mild  K/k/10
679/98 16.10.98 29a,b White patch, right buccal mucosa ND ND L/l/5
209L(1)/99 26.3.99 29 White patch, left buccal mucosa U/w/21
209R/99 26.3.99 29 White patch, right buccal mucosa U/w/21
626/93 4.11.93 30a,b Polyp, right buccal mucosa None None A/a/1
91R/94 22.2.94 30 Angular cheilitis, right commissure ND ND A/a/1
91L/94 22.2.94 30 Angular cheilitis, left commissure A/a/1
Continued on next page
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RESULTS
All 67 isolates of C. albicans examined in this study were
amenable to typing by both IR PCR- and M13-mediated geno-
typing. Replicate IR PCR analysis produced identical PCR
profiles in all instances. However, variations were observed in
the intensities of faintly staining M13 PCR products between
reactions. Identical banding profiles were obtained over a 10-
to 100-fold range of DNA template concentrations for all three
PCRs (data not shown).
The resolution of the banding patterns varied according to
the primer choice. Examples of the patterns obtained by the
prokaryotic consensus repeat motifs and eukaryotic repeat-like
primers are presented in Fig. 1 and 2. Primer combination
1245-1246 generated a profile of unevenly staining polymor-
phic bands (mean of six bands) in the 100- to 800-bp region for
each strain. The single primer 1251 rendered discrete evenly
staining banding patterns, with a mean of eight bands per
isolate ranging in size from 400 to 1,300 bp. The similarity of
IR PCR patterns with primer 1251 among the isolates of C.
albicans examined was more obvious than with 1245-1246
primer pairing. The M13 primer generated the lowest number
of amplification products, typically consisting of several closely
packed faint bands in the 800- to 1,200-bp region, occasionally
with a predominant single 600-bp band (Fig. 3).
For the 67 isolates examined, visual analysis allowed the
categorization of the profiles into 25 (1245 and 1246 primers),
TABLE 1—Continued
Isolate Date isolated(day.mo.yr)
Patient
no. Infection, location
Severity of
dysplasiac
Hyphal
invasiond
Genotype
(I/II/III)e
827/99 5.10.99 31 White patch, tongue ND ND V/x/22
718/99 3.9.99 32 White patch, tongue ND ND D/d/1
WK1/93 1993 33a Healthy buccal mucosa ND ND N/n/15
WK2/00 2000 33 Healthy buccal mucosa N/n/15
DW1/93 1993 34 Healthy buccal mucosa ND ND W/y/23
PB1/93 1993 35 Healthy buccal mucosa ND ND X/z/24
LR1/93 1993 36 Healthy buccal mucosa ND ND Y/a/25
a Individual from whom sequential isolates were available.
b Individual from whom isolates from multiple oral sites were available.
c ND, not determined; NA, not applicable.
d , high; , moderate; , low.
e DNA composite type: I, primer combination 1245–1246; II, primer 1251; III, primer M13.
f , atypical C. albicans profile.
g SCC, squamous cell carcinoma.
FIG. 1. Representative IR PCR profiles of Candida isolates amplified with the primer pair 1245-1246. A negative image is shown. Lanes M,
50-bp ladder, with sizes indicated on the left; lanes 1 to 24, Candida isolates 372LB/94, 600R/93, 134a/94, 718/99, 456P/94, 332L1/97*, 376R/98,
376L/98, 775(1)/99, 79(2)/99**, 79(1)/99, 332R1/97*, 552/99, 680/98, 458R/94, 965R/97, 408/99, 91L/94, 243/00, 324LA/94, 209L(1)/99*, 674/93,
59/94, and 45/99**. , atypical C. albicans profile; , non-C. albicans.
VOL. 39, 2001 PCR FINGERPRINTING OF CANDIDA ALBICANS FROM CHC 4069
 o
n
 February 25, 2014 by Cardiff Univ
http://jcm.asm.org/
D
ow
nloaded from
 
27 (1251 primer), and 25 (M13 primer) types. The banding
patterns obtained were encoded with letters “A” to “Y” (1245
and 1246 primers) and “a” to “a” (1251 primer) and with
numbers “1” to “25” (M13 primer). The results of all the PCR
typing assays are collated in Table 1. Generally, there was
excellent agreement between the identical profiles identified
by the IR PCR techniques. The slight disagreement was caused
by the 1251 primer further differentiating strains 196D/94 (L/p)
and 79(1)/99 (L/r), which were assigned to an identical geno-
type by 1245-1246 PCR. Less agreement was found between
the identical profiles delineated by M13 PCR and IR PCR.
Strain associations derived only from IR PCR were considered
further in this study because of the reduced correlation and
reproducibility evident for the M13 PCR assay.
For six out of nine individuals from whom isolates were
available from multiple oral sites, the same IR PCR pattern
was observed for the isolates (Table 1). The remaining three
subjects carried two distinct strain types within the oral cavity.
Two or more sequential isolates of C. albicans were obtained
from eight subjects up to 7 years apart, allowing the longitu-
dinal analysis of oral candidal colonization (Table 1). In five of
these individuals, strain persistence was demonstrated. One of
the three subjects exhibiting strain replacement (patient 6) was
colonized with two different strain types that alternated
throughout each episode of CHC infection during a 5-year
observation period.
Dendrograms based on IR PCR analysis are presented in
Fig. 4A (1245-1246 PCR) and Fig. 4B (1251 PCR). Both IR
PCR assays identified seven genotypes shared among strains
from unrelated hosts at 100% similarity. The clustering capac-
ities of IR PCR methods demonstrated moderate levels of
correlation between the assays. On superficial inspection, a
closely related IR PCR profile predominated among the ma-
jority of the clinical isolates of C. albicans. The remainder of
the isolates exhibited significantly more variation from the
common profile to be placed outside the main group.
Individuals with a specific disease condition were not found
to harbor a distinct genotype of C. albicans isolates. A com-
parative examination of the 67 isolates failed to corroborate
any obvious differences in the genotypic variability in the CHC
and non-CHC patient groups. This was further supported by
the fact that in each of the dendrograms, clusters included
isolates from both clinical categories. In addition, no subgroup-
ing of the isolates occurred according to the degree of dyspla-
sia or hyphal invasion as assessed from the biopsies of the
lesions (data not shown).
DISCUSSION
This study was concerned with the genotypic and compara-
tive analysis of 67 C. albicans isolates obtained over a period of
7 years from 36 patients. The study was performed to help
clarify the conflicting reports of an association of particular C.
albicans biotypes with CHC (25, 43). Three PCR fingerprinting
methods involving IR PCR (primers 1245 and 1246 and primer
1251) and M13 PCR-mediated genotyping were used to assess
the genetic relatedness of C. albicans isolates from CHC and
non-CHC patient populations.
FIG. 2. Representative IR PCR profiles of Candida isolates amplified with the 1251 primer. A negative image is shown. Lanes M, 100-bp ladder,
with sizes indicated on the left; lanes 1 to 24, Candida isolates 153(2)/00**, 153(1)/00, 319b/94, 135BM1/94, 775(2)/99**, 1190/97, 122rgh/94**,
122/94**, 848/99, 332T1/97*, 135BM2/94, 135MX2/94, 135MX1/94, 372RB/94, 870/99, WK1/93, WK2/00, 689/99, 460(1)/98*, DW1/93, 80/99,
PTR/94, 688/94, and 211/00. , atypical C. albicans profile; , non-C. albicans.
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Primer 1251 was found to be the most effective primer for
the detection of DNA polymorphism between strains of C.
albicans. Overall, the IR PCR methods were more reproduc-
ible than M13 PCR. Variations in the intensities of fragments
amplified with the M13 primer, particularly with the low-in-
tensity bands, compromised the reproducibility of the method,
as noted previously (34). These low-intensity bands may result
from minor variations in the PCR conditions or inefficient
amplification due to mismatch between the primer and the
target sequence (12, 13). The most appreciable difference be-
tween the methods used in this study was the ease of inter-
preting the PCR banding profiles. The 1251 profiles generated
were unambiguous due to the high resolution of the amplified
bands and hence were more amenable to computer-assisted
analysis. The more complex and uneven patterns generated by
ERIC (1245/6) and M13 PCR were found to be less suitable
for visual comparison and required considerably more effort in
introducing the fingerprinting data into the database. Conse-
quently, the analyses of strain association were restricted to the
profiles obtained by IR PCR.
In the present study, one or two individual genotypes colo-
nized any given patient within the oral cavity. The majority of
the patients sampled at multiple sites within the mouth (six out
of nine) were colonized by a single genotype of C. albicans. The
finding of a limited number of genotypes within a body location
has been interpreted as being indicative of a clonal origin for
these strains of commensal and infecting isolates of C. albicans
(8, 16).
The occurrence of strain persistence in five out of eight
individuals is consistent with other epidemiological studies of
recurrent candidoses (33). In the present study, the same strain
of C. albicans was isolated from a CHC lesion on the tongue
over a 7-year period in patient 13. Similarly, patient 16, origi-
nally diagnosed with CHC in 1994, was found to be colonized
by an identical strain of C. albicans 6 years later following
treatment for oral squamous cell carcinoma. Furthermore, pa-
tient 33 was shown to be colonized with the same strain of C.
albicans when sampled over a 7-year interval from a healthy
buccal mucosa. The stability of colonizing populations of C.
albicans within the mouth highlights the successful adaptation
of the organism as a commensal within the oral niche.
Strain replacement has been documented in a minority of
cases, due to acquisition of either a new strain of C. albicans or
a different Candida species. This could arise through an initial
colonization by multiple strains or by recolonization from an
exogenous source (31). Furthermore, reported cases of strain
replacement may in part be explained by small sampling num-
bers (15). In the present study, three patients exhibited strain
replacement. Subject 1 possessed two distinct genotypes of C.
albicans isolated 2 months apart from a CHC lesion on the
buccal mucosa. Subject 29 clinically presented with a white
patch on the buccal mucosa and from this site two distinct
strains were recovered over a period of 6 months. The remain-
ing individual, subject 6, a CHC patient, was found to be
colonized by two strain types in the commissure region of the
buccal mucosa over 5 years.
It has been postulated that strain diversity may contribute to
treatment failure of CHC lesions (25). Strain differentiation by
biotyping has indicated the presence of a more homogeneous
composition of the oral mycoflora in patients with reversible
candidal lesions than in patients with nonreversible lesions. It
has been speculated that variations in the genotype could stra-
FIG. 3. Representative M13 PCR profiles of Candida isolates amplified with the M13 core sequence. A negative image is shown. Lanes M,
100-bp ladder, with sizes indicated on the left; lanes 1 to 24, Candida isolates 332T1/97*, 135BM2/94, 135MX2/94, 135MX1/94, 372RB/94, 870/99,
WK1/93, WK2/00, 689/99, 460(1)/98*, DW1/93, 80/99, PTR/94, 688/94, 211/00, 455rgh/94, 455sm/94, PB1/93, 372F/94, 91R/94, 196D/94, 684/93**,
458L/94**, and 965L/97*. , atypical C. albicans profile; , non-C. albicans.
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FIG. 4. Unweighted pair group method with arithmetic average dendrograms generated from the similarity values determined by the Dice
coefficient according to the IR PCR profiles of 67 C. albicans isolates. Strain reference, subject, and clinical category details are listed on the right.
LP, lichen planus; SCC, squamous cell carcinoma; FEP, fibroepithelial polyp. (A) Primer combination 1245-1246. (B) Primer 1251. , atypical
profile of C. albicans.
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FIG. 4—Continued.
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tegically enhance survival of an organism in the human oral
cavity and trigger the induction of genes to change from a
commensal to an invasive phenotype in response to the local
environment (40). Five of the 17 CHC patients included in this
study were found to be colonized by Candida species other
than C. albicans (data not shown). Further investigation is
required to assess the contribution of these species to CHC
progression.
The finding of strain persistence in CHC patients despite the
provision of antifungal therapy suggests that the clinical recur-
rence of the condition may be due to failure of the antifungal
therapy to eradicate the colonizing strain. Although topical
antifungal therapy has been shown to effectively reduce lesion
sizes and resolve clinical symptoms in approximately a third of
cases, the prevalence of yeast colonization remains persistently
high (14). Groups have expressed caution in using prophylactic
antifungals, mindful of the selection and emergence of drug-
resistant strains (24). Further studies are required to deter-
mine whether the long-term use of antifungals in CHC patients
is beneficial. Perhaps the eradication of yeast from the oral
cavity is an unrealistic proposition, and instead, efforts should
be concentrated on addressing the host factors that predispose
to candida infection, in particular smoking.
In the present study, seven genotypes were shared among 35
apparently epidemiologically unrelated patients. Previous mo-
lecular epidemiology studies have demonstrated that different
persons can harbor the same or very similar genotypes of C.
albicans (44). Explanations for the close relatedness of patient
samples include possible strain transmission and geographical
specificity of C. albicans colonizing populations (23). Epidemi-
ological studies using repetitive probes have found that in a
given patient population a single cluster of genetically related
C. albicans isolates usually predominates, acting as an etiologic
agent in all forms of candidosis, regardless of patient type or
infection (28). The widespread nature of these endemic strains
may result from natural selection favoring the colonization of
a specific genotype of C. albicans. The considerable genetic
similarity among geographically diverse populations of C. al-
bicans isolates has been taken as evidence consistent with a
predominantly clonal population structure (5, 6).
Although shared genotypes existed among the patients in
the present study, approximately one-half of unrelated individ-
uals (17 out of 36) harbored C. albicans strains with unique
profiles. The finding of significant strain diversity, with the
majority of patients being colonized or infected with their own
distinct strain of C. albicans, has lent support to the concept of
endogenous infection (15).
There was a general agreement between the dendrograms,
with the partition of two visually atypical profiles (H/h/7 and
U/w/21) from the major clusters of closely related isolates.
Subsequent determination of the identity of these atypical C.
albicans isolates by the API 32C system established that these
eight strains were Candida dubliniensis. The presence of C.
dubliniensis isolates within the strain collection was initially
overlooked due to reliance on the API 20C system, which is
unable to distinguish C. dubliniensis isolates from C. albicans
isolates, for identification (7). Previous workers have utilized
the variation in IR PCR profiles to distinguish between the
closely related isolates of C. dubliniensis and C. albicans (19,
20).
The present report appears to be the first that describes a
possible association of C. dubliniensis with CHC. The finding of
C. dubliniensis isolates within three individuals, patients 6
(CHC), 24 (keratosis), and 29 (undesignated white patch),
raises questions concerning the true prevalence of C. dublini-
ensis associated with candidoses. Further studies to recover
candidal DNA from the formalin-fixed sections would be re-
quired to confirm the identification of the species invading the
oral epithelium of subject 6 (42).
Analysis of the genotypes from the CHC and non-CHC
individuals revealed no clonal restriction among the strains.
The genetic similarity of individual isolates from the different
disease groups was shown to be comparable, with no correla-
tion between the genotypic affiliations and the clinical condi-
tion of the patient. It would appear that the CHC patient
population is not preferentially infected with a distinct group
of C. albicans strains. This is in agreement with earlier reports
that failed to find a link between a particular isolate genotype
and the underlying disease of the respective patient (15, 44).
The lack of clonal restriction lends support to the theory that
host factors play a significant role in the etiology of oral can-
didosis, with strain differences perhaps being less important
(17).
In conclusion, the present study has confirmed the value of
IR PCR-mediated genotyping of C. albicans isolates for epi-
demiological analysis. Of these approaches, the use of primer
1251 was found to generate the most reproducible fingerprint
profiles. Results of the study indicate that clonal populations of
C. albicans are widely distributed and tend to persist within an
individual despite antifungal therapy. However, no specific
strain types were found to be associated with CHC.
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